@article{article, title  = {{Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia}},

 publisher = {{American Society of Hematology}},

 url = {{https://doi.org/10.1182/blood-2019-121870 }},

 year = {{2019}},

 month = {{11}},

 author = {{Vadakekolathu J and Minden MD and Hood T and Church SE and Reeder S and Altmann H and Sullivan AH and Viboch EJ and Patel T and Ibrahimova N and Warren SE et al}},

 doi = {{10.1182/blood-2019-121870}},

 volume = {{134}},

 journal = {{Blood}},

 issue = {{Supplement_1}},

 pages = {{460-460}},

 note = {{Accessed on 2026/02/25}}}